Skip to main content
Clinical Trials/CTRI/2023/03/050346
CTRI/2023/03/050346
Not yet recruiting
未知

Effect of comprehensive rehabilitation program on pain, function and disability in Type 2 Diabetes Mellitus individuals with chronic low back pain

Spry Therapeutics Private Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
Sponsor
Spry Therapeutics Private Limited
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Spry Therapeutics Private Limited

Eligibility Criteria

Inclusion Criteria

  • Phase I: Age 18 to 65 years, participants diagnosed with T2DM and on medication from past 1 year, T2DM with or without peripheral neuropathy, HbA1c \> 6\.4%
  • Phase II: Age 18 to 65 years, history of low back pain LBP \> 3 months, Participants diagnosed with Type 2 Diabetes Mellitus and on medication from past 1 year, HbA1c \> 6\.4%, Numeric pain rating scale \>3, Oswestry disability index Score \>20%.

Exclusion Criteria

  • Phase I: Infections or tumors of the spine, systemic bone or joint disorders, neuromuscular pathology, presence of a diagnosed severe psychiatric disorder, confirmed pregnancy, acute disc prolapse, prolapsed Intervertebral disc of other causes, low back pain due to traumatic causes
  • Phase II: Infections or tumors of the spine, systemic bone or joint disorders, unstable
  • cardiovascular and pulmonary diseases, polyneuropathies and musculoskeletal system diseases, presence of a diagnosed severe psychiatric disorder, confirmed pregnancy, any systemic complications which prevents their participation in study

Outcomes

Primary Outcomes

Not specified

Similar Trials